CompletedNot applicableNCT03024801

Effectiveness of Autologous Platelet-rich Plasma on Knee Cartilage Injury

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese PLA General Hospital
Principal Investigator
Quanyi Guo, Ph.D
Chinese PLA Hospital, China
Intervention
autologous platelet-rich plasma(drug)
Enrollment
50 target
Eligibility
14-55 years · All sexes
Timeline
20122016

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03024801 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials